It will now also be important to establish if the lack of effectivity for Col4a1 renal disease also applies to other kidney pathologies due to mutations in BM components such as Alport syndrome, where PBA reduced ER stress in cells with COL4A5 missense mutations (48). This evidence concerns the gene COL4A5 and Alport syndrome.